Dr. Mekan brings a combined 18 years of experience in hematology and oncology across academic research, clinical practice and biopharmaceutical industry development, and I am excited to welcome her to ...

Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient ...

Oncology Clinical Trials Market has been steadily growing over the years due to increasing incidence of cancer, advancements ...

The determination comes after recruitment and dosing in certain trials were paused after a young patient died due to acute liver failure.

Quantum is partnering with Massachusetts General Hospital on a clinical study to test a PET tracer for monitoring response to treatment in MS.

Mia Love has brought renewed attention to an aggressive form of brain cancer that killed her at age 49 You're thinking of participating in a clinical trial – what now? Ask questions and weigh ...

However, there is a paucity of data on the false-negative (FN) rate. This study evaluated the clinical effectiveness of the Manchester Glaucoma Enhanced Referral Scheme (GERS), estimating both the ...

Fibrobiologics' cell therapy CYMS101 significantly increased myelin production and promoted myelin repair in a mouse model of MS ...

The Health Workers Union (HWU) is asking its more than 200 members at Australian Clinical Laboratories (ACL) in Victoria to vote on an “in-principle agreement” that would further slash the ...

Table 1: Global Virtual Clinical Trials Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032 Table 3: ...

Most candidates tend to go the extra mile to leave a positive impression during a job interview, hoping it will secure the desired position. A collective of hiring managers have recently divulged ...

Wes Streeting has been accused of launching an “unjustified attack” on recruiters after the Health Secretary claimed they were ripping-off the NHS. Mr Streeting wrote in The Times on Wednesday ...